Commentary

Digital Ulcer Disease in Systemic Sclerosis

Publish date: May 18, 2012

 

Dr. Denton reported that he has financial relationships with
Actelion Pharmaceuticals, Aspreva, Biovitrum, Digna,
Encysive Pharmaceuticals, Genzyme, and Pfizer.

Pages

Recommended Reading

HIV Infection Complicates Rheumatologic Treatments and Vice Versa
Psoriasis Collection
Panel Recommends Tofacitinib Approval for Refractory RA
Psoriasis Collection
Biologics for RA Do Not Increase Solid Cancer Risk
Psoriasis Collection
Joint Involvement Less Common in Presence of Sjögren's Autoantibodies
Psoriasis Collection
Avoid Certain Vaccine-Biologic Combos
Psoriasis Collection
Smokers Less Likely to Respond to Biologic Treatment for RA
Psoriasis Collection
Could a Urine Test Predict Response to Biologics?
Psoriasis Collection
ACR Releases Updated Lupus Nephritis Guidelines
Psoriasis Collection
ACR Gives Special Consideration to Pregnancy in Nephritis Guidelines
Psoriasis Collection
Scleroderma Malignancy Risk Linked to Antinuclear Antibodies
Psoriasis Collection